SCHEMBL5263202

SCHEMBL5263202

CCCCOC(=O)N(CC)c1cccc(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.44
LMNA P02545 4/20 0.44
L3MBTL1 Q9Y468 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 5/20 0.40
RAB9A P51151 4/20 0.40
ESR1 P03372 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MCL1 Q07820 1/20 0.40
ATM Q13315 1/20 0.39
CYP3A4 P08684 1/20 0.38
KMT2A Q03164 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27806504 0.84 TSHR (0.41) TSHRLMNAL3MBTL1TDP1ALDH1A1
SCHEMBL21382113 0.83 ALDH1A1 (0.47) TSHRLMNAL3MBTL1TDP1ALDH1A1
SCHEMBL27955327 0.81 ALDH1A1 (0.48) TSHRLMNAL3MBTL1ALDH1A1RAB9A
SCHEMBL27938388 0.80 MAPT (0.48) TSHRLMNAL3MBTL1ALDH1A1RAB9A
SCHEMBL1600710 0.78 HDAC8 (0.41) TSHRLMNAL3MBTL1ALDH1A1RAB9A
SCHEMBL4448680 0.78 APP (0.49) TSHRLMNAL3MBTL1TDP1ALDH1A1
SCHEMBL2083223 0.76 MTNR1A (0.48) TSHRLMNAL3MBTL1ALDH1A1RAB9A
SCHEMBL15320269 0.76 TSHR (0.50) TSHRLMNAL3MBTL1ALDH1A1RAB9A
SCHEMBL4439906 0.76 LMNA (0.38) TSHRLMNAL3MBTL1TDP1ALDH1A1
SCHEMBL5737663 0.76 TSHR (0.55) TSHRLMNAL3MBTL1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO disclosed